Request Reader Training

Cerianna (fluoroestradiol F 18) injection is an estrogen-receptor targeted radiotracer (e-RTR) prescribed to detect whole-body ER+ lesions in recurrent or metastatic breast cancer patients that may inform clinical decisions.

GE Healthcare has designed peer-to-peer reader training programs in a variety of formats to help you accurately interpret Cerianna images.

We offer convenient virtual training to fit your learning style and schedule.

Register using the form below to request a training session. You will be contacted by our training team within 48 hours.

Request Training

GE Healthcare | Privacy Policy | Terms of Use | Contact Us | Unsubscribe

500 W. Monroe Street | Chicago, IL 60661


© 2022 General Electric Company

GE and the GE Monogram are trademarks of the General Electric Company.

JB07297US October/2022